SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001232524-21-000031
Filing Date
2021-05-04
Accepted
2021-05-04 16:45:13
Documents
94
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q jazz-20210331.htm   iXBRL 10-Q 1629160
2 CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) jazzq12021ex311.htm EX-31.1 10378
3 CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) jazzq12021ex312.htm EX-31.2 10374
4 CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 jazzq12021ex321.htm EX-32.1 7085
  Complete submission text file 0001232524-21-000031.txt   8389315

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jazz-20210331.xsd EX-101.SCH 59281
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT jazz-20210331_cal.xml EX-101.CAL 130038
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jazz-20210331_def.xml EX-101.DEF 308218
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jazz-20210331_lab.xml EX-101.LAB 717023
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jazz-20210331_pre.xml EX-101.PRE 481025
10 EXTRACTED XBRL INSTANCE DOCUMENT jazz-20210331_htm.xml XML 1490081
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33500 | Film No.: 21889277
SIC: 2834 Pharmaceutical Preparations